The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
96453265 9645326 5 F 199703 20160816 20131025 20160823 EXP US-009507513-1203USA02324 MERCK 0.00 F Y 72.56000 KG 20160823 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
96453265 9645326 1 PS FOSAMAX ALENDRONATE SODIUM 1 Oral 10 MG, QD 4510 MG U 20560 10 MG TABLET QD
96453265 9645326 2 SS FOSAMAX ALENDRONATE SODIUM 1 Oral 70 MG, QW 4510 MG U 20560 70 MG TABLET /wk
96453265 9645326 3 SS ALENDRONATE SODIUM. ALENDRONATE SODIUM 1 Oral 70 MG, QW U 0 70 MG /wk
96453265 9645326 4 SS ALENDRONATE SODIUM. ALENDRONATE SODIUM 1 Oral 70 MG, QW U 0 70 MG /wk
96453265 9645326 5 SS BONIVA IBANDRONATE SODIUM 1 Oral 150 MG, UNK 0 150 MG
96453265 9645326 6 C PREMARIN ESTROGENS, CONJUGATED 1 Unknown 0.625 MG, QD U U 0 .625 MG QD
96453265 9645326 7 C CALTRATE WITH VITAMIN D CALCIUM CARBONATECHOLECALCIFEROL 1 Unknown 500-600 MG, TID U U 0 TID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
96453265 9645326 1 Osteoporosis
96453265 9645326 3 Osteoporosis
96453265 9645326 5 Osteoporosis
96453265 9645326 6 Osteoporosis
96453265 9645326 7 Osteoporosis

Outcome of event

Event ID CASEID OUTC COD
96453265 9645326 HO
96453265 9645326 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
96453265 9645326 Abdominal hernia
96453265 9645326 Abdominal hernia repair
96453265 9645326 Anaemia
96453265 9645326 Anaemia postoperative
96453265 9645326 Angiopathy
96453265 9645326 Arteriosclerosis
96453265 9645326 Arthralgia
96453265 9645326 Arthritis
96453265 9645326 Blood pressure increased
96453265 9645326 Bone density decreased
96453265 9645326 Cardiac disorder
96453265 9645326 Cardiac murmur
96453265 9645326 Cardiomegaly
96453265 9645326 Closed fracture manipulation
96453265 9645326 Contusion
96453265 9645326 Cystocele
96453265 9645326 Cystoscopy
96453265 9645326 Dizziness postural
96453265 9645326 Dyslipidaemia
96453265 9645326 Extrasystoles
96453265 9645326 Eye contusion
96453265 9645326 Fall
96453265 9645326 Femoral neck fracture
96453265 9645326 Femur fracture
96453265 9645326 Heart rate irregular
96453265 9645326 Hypertension
96453265 9645326 Hypothyroidism
96453265 9645326 Low turnover osteopathy
96453265 9645326 Micturition urgency
96453265 9645326 Muscle spasms
96453265 9645326 Muscle strain
96453265 9645326 Musculoskeletal chest pain
96453265 9645326 Nocturia
96453265 9645326 Orbital oedema
96453265 9645326 Osteoarthritis
96453265 9645326 Skeletal traction
96453265 9645326 Thyroidectomy
96453265 9645326 Urge incontinence
96453265 9645326 Visual impairment

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
96453265 9645326 1 199701 19980327 0
96453265 9645326 2 20040209 20061010 0
96453265 9645326 3 20090429 0
96453265 9645326 4 20100104 20100907 0
96453265 9645326 5 20050816 20051122 0
96453265 9645326 6 1997 0
96453265 9645326 7 1997 0